Archive | Bachem AG

Page 9 of 19
Bachem enters strategic collaboration with Lilly to manufacture oligonucleotide-based drug substances
Bachem enters strategic collaboration with Lilly to manufacture oligonucleotide-based drug substances Learn More >
Bachem to present oligo purification advances at IOPC Milan
Bachem to present oligo purification advances at IOPC Milan Learn More >
Bachem webinar on reducing risk of nitrosamine contamination of SPPS-produced peptide APIs
Bachem webinar on reducing risk of nitrosamine contamination of SPPS-produced peptide APIs Learn More >
Bachem – Oligo Therapeutics – Innovation that Transforms Lives
Bachem – Oligo Therapeutics – Innovation that Transforms Lives Learn More >
Bachem showcasing Custom Synthesis offerings at Franco-Belgian GFPP22 meeting
Bachem showcasing Custom Synthesis offerings at Franco-Belgian GFPP22 meeting Learn More >
Bachem expands large-scale oligonucleotide manufacturing capabilities
Bachem expands large-scale oligonucleotide manufacturing capabilities Learn More >
51608Bachem Cell-Penetrating Peptides (CPPs) as delivery systems for Oligonucleotides
Bachem Cell-Penetrating Peptides (CPPs) as delivery systems for Oligonucleotides Learn More >
Bachem showcasing advanced ‘tides capabilities’ at CPhI North America
Bachem showcasing advanced ‘tides capabilities’ at CPhI North America Learn More >
Bachem webinar on binary solvents for greener SPPS peptide synthesis
Bachem webinar on binary solvents for greener SPPS peptide synthesis Learn More >
51491Oligonucleotides – Innovation that transforms lives
Oligonucleotides – Innovation that transforms lives Learn More >
Bachem featuring CMC development of peptides and oligos at BioMed Israel
Bachem featuring CMC development of peptides and oligos at BioMed Israel Learn More >
Bachem bringing innovative tide development and manufacturing technologies to TIDES USA
Bachem bringing innovative tide development and manufacturing technologies to TIDES USA Learn More >
Page 9 of 19